Tag: NCT02561988

Home / NCT02561988

Categories

Avapritinib has been approved by the FDA for advanced systemic mastocytosis

August 2021: The FDA approved avapritinib (AyvakitTM, Blueprint Medicines Corp.) for adult patients with advanced systemic mastocytosis (AdvSM), which includes aggressive systemic mastocytosis (ASM), ...
nct02561988

Scan the code